Previous research has documented racial/ethnic disparities in diabetes treatments and outcomes. It remains controversial whether these disparities result from differences in socioeconomic status (SES) or other factors. We examined racial/ethnic disparities in therapeutic modalities and diabetes outcomes among the large number of pediatric participants in the T1D Exchange Clinic Registry.
METHODS:
The cohort included 10 704 participants aged ,18 years with type 1 diabetes for $1 year (48% female; mean age: 11.9 6 3.6 years; diabetes duration: 5.2 6 3.5 years). Diabetes management and clinical outcomes were compared among 8841 non-Hispanic white (white) (83%), 697 non-Hispanic black (black) (7%), and 1166 Hispanic (11%) participants. The population included 214 high-income black and Hispanic families.
RESULTS: Insulin pump use was higher in white participants than in black or Hispanic participants (61% vs 26% and 39%, respectively) after adjusting for gender, age, diabetes duration, and SES (P , .001). Mean hemoglobin A1c was higher (adjusted P , .001) in black participants than in white or Hispanic participants (9.6%, 8.4%, and 8.7% ). More black participants experienced diabetic ketoacidosis and severe hypoglycemic events in the previous year than white or Hispanic participants (both, P , .001). There were no significant differences in hemoglobin A1c, diabetic ketoacidosis, or severe hypoglycemia between white and Hispanic participants after adjustment for SES.
CONCLUSIONS: Even after SES adjustment, marked disparities in insulin treatment method and treatment outcomes existed between black versus Hispanic and white children within this large pediatric cohort. Barriers to insulin pump use and optimal glycemic control beyond SES should be explored in all ethnic groups.
WHAT'S KNOWN ON THIS SUBJECT:
Previous studies have demonstrated racial and ethnic differences in glycemic control even after adjustment for variables such as insulin dosage, diabetes duration, and socioeconomic status. It is controversial whether genetic, physiologic, cultural, socioeconomic, and/or provider-related factors underlie these disparities.
WHAT THIS STUDY ADDS:
This study in a large, racially/ethnically diverse sample of children with type 1 diabetes demonstrates that racial disparities in insulin treatment methods and diabetes outcomes remain even after adjustment for socioeconomic status.
Despite significant advancements in the care of children with chronic illnesses, racial and ethnic inequities in care delivery and health outcomes persist in the United States. 1 These inequities are especially troubling in children with type 1 diabetes whose anticipated long duration of disease places them at risk for acute and chronic complications, particularly in the presence of suboptimal care. 2 Previous studies of children with type 1 diabetes have found that nonHispanic black (black) children tend to have poorer glycemic control than non-Hispanic white (white) children as evidenced by higher hemoglobin A1c (HbA1c) values; many studies suggest that glycemic control in Hispanic children is intermediate (ie, between that of white and black subjects). 1, [3] [4] [5] [6] [7] [8] [9] [10] Poor glycemic control has been associated with a ninefold higher mortality rate among black subjects compared with white subjects with type 1 diabetes aged ,25 years, primarily due to an increased incidence of diabetic ketoacidosis (DKA) in black subjects. 11 Racial/ethnic disparities have also been reported in treatment regimens used in pediatric patients with type 1 diabetes. The SEARCH (Search for Diabetes in Youth) study found that 26.3% of white children reported using insulin pump therapy compared with only 12.3% of Hispanic children and 5.3% of black children. 12 In a more recent study, Valenzuela et al 13 reported that black and Hispanic youth were consistently receiving less intensive insulin regimens than white youth, including the fact that far fewer minority children were receiving pump treatment.
It remains controversial to what extent genetic, physiologic, 14 cultural, socioeconomic, 15 and providerrelated 13 factors underlie observed racial and ethnic disparities in treatment regimens and clinical outcomes. [16] [17] [18] Although some studies support the contention that socioeconomic status (SES) is more important than race as a predictor of glycemic control in pediatric populations, 10 the impact of SES has been difficult to establish due to the small number of high-income black and Hispanic families in the majority of these studies. Established in 2010, the T1D Exchange Clinic Registry enrolled .10 000 children and adolescents with type 1 diabetes 19 from 60 leading diabetes treatment centers across 31 US states. This patient population included .1800 black and Hispanic families, of whom 214 reported annual household incomes more than $100 000 per year. The size and the economic diversity of our patient sample allowed us to examine whether racial and ethnic disparities in treatment methods and clinical outcomes of US youth with type 1 diabetes persisted in minority children after controlling for differences in SES.
METHODS
The T1D Exchange Clinic Network includes 73 US-based pediatric and adult endocrinology practices. The network commenced enrollment of subjects with type 1 diabetes into a clinic registry beginning in September 2010. 19 Demographic characteristics were tabulated and assessed for race/ethnicity differences by using linear and logistic regression models. Binary mixed models with clinical center identification as a random effect were used to assess the association between race/ethnicity and binary outcomes of insulin pump use, $1 DKA event in the past 12 months, and $1 SH event in the past 12 months. This assessment was made after adjusting for potential confounders, including age group, gender, diabetes duration, interaction between age group and diabetes duration (pump analysis only), insulin method (SH and DKA analyses), annual household income, and highest parental education level. Linear mixed models with clinical center identification as a random effect were used to assess the relationship between race/ethnicity and mean HbA1c level, meter glucose, and SMBG per day, after adjusting for potential confounders. These confounders included age group, insulin delivery method (SMBG only), gender, continuous glucose monitoring use (SMBG only), BMI z score (HbA1c only), highest level of parental education, and annual household income. Interaction terms between covariates included in the multivariate models were assessed and included in the model if the P value was ,.01. Separate models stratified according to household income and highest parental education level were constructed. The interaction between race/ethnicity and insulin delivery method on mean HbA1c was assessed, and separate models stratified according to age group and insulin delivery method were constructed. Race/ethnicity differences in time from diagnosis to initiation of an insulin pump among pump users, stratified according to age at diagnosis of type 1 diabetes, were assessed by using Wilcoxon rank tests. Similar results were produced when analyses: (1) excluded sites with ,5% minority participants (668 participants excluded); and (2) excluded participants without "definite type 1 diabetes," defined as age at diagnosis ,10 years or history of positive antibodies (collected from the medical record). A total of 1025 participants did not meet the criteria for definite type 1 diabetes: 10% of white, 10% of black, and 9% of Hispanic participants.
Missing covariates were treated as a separate category for discrete variables, and a missing value indicator was added to the model for continuous variables. Due to multiple comparisons and the large sample size, only P values ,.01 were considered statistically significant. All reported P values are 2-sided. Data analyses were conducted by using SAS version 9.4 (2011; SAS Institute, Inc, Cary, NC).
RESULTS

Subjects
The cohort consisted of 8841 white (83%), 697 black (7%), and 1166 Hispanic (11%) children (mean age: 11.9 6 3.6 years; 48% female; mean diabetes duration: 5.2 6 3.5 years). Demographic characteristics according to race/ethnicity are shown in Table 1 . White participants were less likely to be female (P , .001) and overweight/obese (P , .001) compared with black and Hispanic participants. There were differences in SES distributions by race/ethnicity; 76% of families of white participants had a household income at least $50 000 compared with only 36% of black families and 46% of Hispanic families (P , .001). Similar differences between white, black, and Hispanic participants existed with respect to parents having formal education beyond high school (71% vs 47% and 42%, respectively; P , .001) and having private insurance (79% vs 39% and 50%, respectively; P , .001).
Disparities in Diabetes Management
Insulin Pump Use
Overall, 57% of the study sample was utilizing insulin pump therapy, and 43% were taking insulin injections. White children had the highest percentage of pump use even after controlling for gender, age, diabetes duration, and SES (P , .001) (Fig 1 , Table 2 ). The odds of a white child being on insulin pump therapy were 3.6 times higher than a black child (95% confidence interval [CI]: 2.9-4.7) and 1.9 times higher than a Hispanic child (95% CI: 1.6-2.2). Differences in pump use between white and black children (but not Hispanic children) were present across all reported income levels. The proportion of black children using an insulin pump whose annual household income was at least $100 000 (45%) was the same as that of white children whose annual household income was less than $50 000. When household income exceeded $50 000, pump use in Hispanic families was similar to white families and was significantly more frequent than in black families.
Similarly, white children without private insurance were more than twice as likely to be using an insulin pump as black children in the same insurance category (47% among white children vs 21% among black children; P , .001). The percentage of white children without private insurance using insulin pumps was greater than the percentage of black children with private insurance using insulin pumps (47% vs 36%; P = .006). These disparities persisted even when data were stratified according to highest parental education level (Supplemental Table 3 ). For example, 68% of white children whose parents had a college or graduate degree were using an insulin pump compared with 34% of black children whose parents had college or graduate school degrees (P , .001). Race/ethnicity disparities in insulin pump use according to demographic characteristics are shown in Supplemental Table 4 .
The proportion of participants using an insulin pump ranged from 6% to 90% among the 49 clinics with at least 30 participants. Frequency of pump use in clinics with ,50 participants (n = 17), 50 to ,200 participants (n = 23), and $200 participants (n = 20) was 61%, 57%, and 60%, respectively. Among the 25 clinics with at least 10 white participants and 10 black participants, the difference in the proportion of white versus black participants using an insulin pump ranged from 9% to 51% across clinics, and the mean difference was similar between clinic size (27% for clinics with ,200 participants and 35% for clinics with $200 participants). Among the 24 clinics with at least 10 white participants and 10 Hispanic participants, the difference in the proportion of white versus Hispanic participants using an insulin pump ranged from -9% to 47% across clinics, and the mean difference was similar between clinic sizes (25% for clinics with ,200 participants and 21% for clinics with $200 participants).
In all racial/ethnic groups, older children were prescribed insulin pump therapy sooner after diagnosis than young children. Among children diagnosed at ,6 years of age, the median diabetes duration before pump initiation in the white, black, and Hispanic groups, respectively,
FIGURE 1
Insulin delivery regimen/method according to age and race/ethnicity. White section, pump users; black section, multiple daily injections; black and white striped section, fixed dose users.
was 2, 3, and 3 years (P = .005). In contrast, these median durations were 1, 2, and 2 years among children diagnosed at ages 6 to ,13 years (P = .009) and 1 year among children for all race/ethnicity groups who were diagnosed at ages 13 to ,18 years (P = .89).
SMBG Measurements per Day
The mean number of self-reported SMBG measurements per day was 6.1, 5.4, and 5.6 in white, black, and Hispanic participants, respectively (P , .001 adjusted for age, diabetes duration, insulin delivery method, continuous glucose monitor use, gender, and SES) ( Table 2) . Among participants whose household income was less than $50 000, 10% of white participants reported checking glucose levels #3 times per day compared with 21% of black participants (P = .003).
Medical record reports from blood glucose meters indicate that the average number of checks per day were available for 55%, 47%, and 69% of white, black, and Hispanic participants, respectively. The mean number of meter-verified glucose measurements per day was 5.3 among white participants compared with 4.0 and 4.5 among black and Hispanic participants (P , .001).
Diabetes Outcomes
The most recent mean HbA1c level was 8.4% 6 1.4% among white (5) 70 (13) 49 (6) ,.001/.62/,.001 $1 DKA event in past 12 mo e 641 (7) 153 (23) 137 (12) ,.001/.04/,.001 Annual household income ,$50 000 n = 1578 n = 286 n = 421 Insulin pump use a 702 (45) 65 (23) (7) 12 (12) 17 (9) .04/.85/.14 Annual household income $$100 000 n = 2496 n = 58 n = 156 Insulin pump use b 1815 (73) 26 (45) (4) 4 (9) 5 (4) .35/.71/.64 $1 DKA event in past 12 mo e 94 (4) 12 (21) 13 (8) ,.001/.01/.02 Annual household income: not provided n = 2286 n = 252 n = 391 Insulin pump use b 1323 (58) 54 (22) (5) 20 (12) 13 (5) .003/.96/.03 $1 DKA event in past 12 mo e 179 (9) 47 (22) 40 (11) ,.001/.94/.002
Data are presented as n (%) or mean 6 SD. a A total of 44 participants were using both an insulin pump and injections and were not included in the analysis. Binary mixed models were adjusted for age, diabetes duration, interaction between age and diabetes duration, gender, highest parental education level (missing data imputed for ordinal variable and missing indicator included in model), annual household income (missing data imputed for ordinal variable and missing indicator included in model; not included in stratified models), and random site effect. b A total of 394 participants were missing self-reported SMBG per day data (8552 white, 652 black, and 1106 Hispanic subjects). Linear mixed models were adjusted for age, insulin method, continuous glucose monitoring use, gender, highest parental education level (missing data imputed for ordinal variable and missing indicator included in model), annual household income (missing data imputed for ordinal variable and missing indicator included in model; not included in stratified models), and random site effect. c Linear mixed models were adjusted for age, gender, BMI z score, highest parental education level (missing data imputed for ordinal variable and missing indicator included in model), annual household income (missing data imputed for ordinal variable and missing indicator included in model; not included in stratified models), and random site effect. d A total of 4298 participants were missing SH data due to a change in how an SH event was defined during the enrollment period (6406 white, 525 black, and 1120 Hispanic subjects). Binary mixed models were adjusted for age, diabetes duration, gender, insulin method, SMBG per day, highest parental education level (missing data imputed for ordinal variable and missing indicator included in model), annual household income (missing data imputed for ordinal variable and missing indicator included in model; not included in stratified models), and random site effect. e A total of 307 participants were missing DKA event data (8618 white, 659 black, and 1120 Hispanic subjects). Binary mixed models were adjusted for age, diabetes duration, gender, insulin method, SMBG per day, highest parental education level (missing data imputed for ordinal variable and missing indicator included in model), annual household income (missing data imputed for ordinal variable and missing indicator included in model; not included in stratified models), and random site effect.
participants, 9.6% 6 1.9% among black participants, and 8.7% 6 1.6% among Hispanic participants. Significant differences in mean HbA1c concentrations were observed between black versus white participants (P , .001) and black versus Hispanic participants (P , .001) even after adjustment for SES. However, in an adjusted model, there was no significant difference in HbA1c between Hispanic participants versus white participants (P = .02). In all 3 racial/ethnic groups, HbA1c values were lower among participants using a pump versus multiple daily injections or fixed-dose injections, with the pump-injection difference being greatest among black participants (P , .001 for interaction between race/ethnicity and insulin method) (Fig 2) . There was a greater disparity in mean HbA1c values among adolescents versus younger children, but the overall patterns among the racial and ethnic groups within age categories did not differ.
Mean glucose from a meter download at the most recent clinic visit was available in 52%, 43%, and 65% of white, black, and Hispanic participants, respectively. Mean glucose was 208 mg/dL among white participants compared with 234 mg/dL among black participants (adjusted P , .001) and 213 mg/dL in Hispanic participants (adjusted P = .34). As shown in Supplemental Table 5 , there were similar, stepwise increases in mean blood glucose levels, with increasing HbA1c levels within each ethnic/racial group.
Mean HbA1c levels ranged from 7.8% to 9.9% among the 49 clinics with at least 30 participants. The average HbA1c value in clinics with ,50 participants (n = 17), 50 to ,200 participants (n = 23), and $200 participants (n = 20) was 8.7%, 8.6%, and 8.5%, respectively. Among the 25 clinics with at least 10 white participants and 10 black participants, the difference in mean HbA1c between white versus black participants ranged from -1.9% to -0.8% across clinics and was similar with respect to clinic size (-1.2% for clinics with ,200 participants and -1.1% for clinics with $200 participants). Among the 24 clinics with at least 10 white participants and 10 Hispanic participants, the difference in mean HbA1c levels between white versus Hispanic participants ranged from -1.6% to 0.2% across clinics and was similar with respect to clinic size (-0.4% for clinics with ,200 participants and -0.4% for clinics with $200 participants).
More black participants had DKA and SH events in the previous 12 months than white or Hispanic participants ( 1.6-3.5] ; P , 0. 001).
DISCUSSION
When examined as a group, there were significant disparities in treatment regimens and diabetes outcomes in black and Hispanic children compared with white children in our patient population. Perhaps our most notable finding is that the disparities in treatment methods and clinical outcomes between white and black children persisted even after adjustments for SES. Far fewer black than white children across all income strata were using insulin pumps, which may, in part, explain the much higher HbA1c levels observed even in high-income black families. Elevated HbA1c levels and less frequent blood glucose monitoring are likely to have contributed to the increased risk of DKA in black patients as well. The rates of SH were also increased in black patients, notwithstanding the higher HbA1c and glucose levels. Differences in the risk of DKA and SH between black and white children persisted even after adjustment for annual household income and highest parental education level.
It is particularly strikingly that the proportion of black children using an insulin pump whose annual
FIGURE 2
Mean HbA1c level according to race/ethnicity and insulin regimen/method. MDI, multiple daily injections. White bar, non-Hispanic white; black bar, non-Hispanic black; black and white striped bar, Hispanic.
household income was at least $100 000 (45%) was the same as that of white children whose annual household income was less than $50 000. Similarly, black children with private insurance were less likely to be prescribed insulin pump therapy than white children without private insurance. Furthermore, HbA1c levels were higher in black children from the uppermost SES strata than among the white children in the lowest of our SES echelons. [20] [21] [22] An analysis of available blood glucose data obtained from meter downloads, however, suggests that the racial disparity in HbA1c was accompanied by a similar disparity in mean blood glucose levels. Language barriers have been suggested to contribute to treatment problems, especially in exclusively Spanish-speaking, lowincome Hispanic families. 23 Several studies have suggested that provider biases related to stereotypes regarding minorities' competence and behaviors contribute to reduced rates of pump use in black and Hispanic families. 13, 24 Due to the need for individualized treatment plans, patients with diabetes may be particularly vulnerable to the consequences of provider biases. 25 This study did not examine the specifics of the decision-making process that precede initiation of insulin pump therapy or assess family and provider factors related to the choice of insulin regimen.
It should be noted that mean HbA1c levels in all 3 ethnic/racial groups in the T1D Exchange Clinic Registry were substantially higher than the target level of ,7.5% recommended by the American Diabetes Association in the newly published 2014 type 1 diabetes guidelines 26, 27 and by the 
